Why the study?
Disruption of pathways affecting ventricular growth may underlie ventricular malformations in children, but precise molecular mechanisms remain to be fully understood.
Answers are grounded in this paper and cite their sources.
Disruption of transcriptional pathways affecting ventricular growth may underlie ventricular hypoplasia in congenital heart disease, suggesting potential for preventive modulation in genetically susceptible individuals.
We have established the beginnings of a road map to understand how ventricular cells become specified, differentiate, and expand into a functional cardiac chamber (Fig. 5). The transcriptional networks described here provide clear evidence that disruption of pathways affecting ventricular growth could be the underlying etiology in a subset of children born with malformation of the right or left ventricle. As we learn details of the precise mechanisms through which the critical factors function, the challenge will lie in devising innovative methods to augment or modify the effects of gene mutations on ventricular development. Because most congenital heart disease likely occurs in a setting of heterozygous, predisposing mutations of one or more genes, modulation of activity of critical pathways in a preventive fashion may be useful in averting disease in genetically susceptible individuals.
No takes yet. Share an insight, caveat, or question.
Srivastava et al. (2002) conducted a review in Ventricular hypoplasia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: